Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis

INTRODUCTION: Vascular devices such as stents, hemodialyzers, and membrane oxygenators can activate blood coagulation and often require the use of systemic anticoagulants to selectively prevent intravascular thrombotic/embolic events or extracorporeal device failure. Coagulation factor (F)XII of the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Mol Bioeng
Autors principals: Kohs, T. C. L., Lorentz, C. U., Johnson, J., Puy, C., Olson, S. R., Shatzel, J. J., Gailani, D., Hinds, M. T., Tucker, E. I., Gruber, A., McCarty, O. J. T., Wallisch, M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010086/
https://ncbi.nlm.nih.gov/pubmed/33868498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12195-020-00657-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars